Lawsuit Claims Birth Control Packaging Error Led to More Than 100 Unwanted Pregnancies The suit seeks millions in damages including, in some cases, child-rearing expenses up to the age of 18.

By Laura Entis

entrepreneur daily

Opinions expressed by Entrepreneur contributors are their own.

Shutterstock

In 2011, Qualitest Pharmaceuticals recalled 1.4 million packages of birth control pills due to a packaging error that reversed the weekly tablet order. Instead of appearing at the bottom of the package, the placebo pills, which are meant to be taken the week of menstruation, were flipped 180 degrees. To be effective, birth control pills must be taken in the proper order.

Now, more than 100 women are suing Qualitest, claiming that the incorrect packaging resulted in unwanted pregnancies. All but four of the 113 women involved became pregnant, and more than 90 gave birth, the Associated Press reports.

Related: Amazon Sues More Than 1,000 People Over Fake Reviews

The suit seeks millions in damages, including recovery for medical expenses, pain and suffering, lost wages and, in some cases, child-rearing expenses up to the age of 18.

The lawsuit was filed this week in Pennsylvania, where Qualitest's parent company Endo Pharmaceuticals is headquartered, directly after a federal judge in Georgia denied class-action certification to a similar suit filed in the state. Vintage Pharmaceuticals and Patheon were also named in the suit.

In a statement to ABC News, Endo Pharmaceuticals said that it had only been able to confirm one defected birth control pack that was sold to a patient.

Endo's statement, in full:

Our commitment is to patient safety and we take product quality very seriously. ... There is no new or recent product recall. The recall that forms the basis of this suit was entirely voluntary and occurred more than four years ago in September 2011. The voluntary recall occurred based on an extremely small number of pill packs that were manufactured by an external contract manufacturer. Endo has been able to confirm only one blister pack that manifested a defect and was sold to a patient. Additionally, courts have dismissed cases arising out of the recall because the plaintiff could not establish that she purchased a defective package.

The FDA's 2011 recall included the following oral contraceptives: Cyclafem 7/7/7, Cyclafem 1/35, Emoquette, Gildess FE 1.5/30, Gildess FE 1/20, Orsythia, Previfem and Tri-Previfem.

Related: Drone Owners Will Soon Have to Register With the Federal Government

Laura Entis is a reporter for Fortune.com's Venture section.

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Editor's Pick

Related Topics

Science & Technology

These Are the Top 6 AI Threats to Your Business Right Now

The modern workforce is forever changed by artificial intelligence. If you fail to understand that we will all need to learn AI to some degree, you haven't been paying attention.

Business News

Here Are 3 Strategies Startup Founders Can Use to Approach High-Impact Disputes

The $7 billion "buy now, pay later" startup Klarna recently faced a public board spat. Here are three strategies to approach conflict within a business.

Business News

I Tested the 'Invest As You Shop' App to See If It Really Makes Investing Less Intimidating

Grifin is an app that tailors a user's investments to their spending habits. Now, the app is getting even more personal.

Business Ideas

55 Small Business Ideas to Start in 2024

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2024.

Business News

Vice Will No Longer Publish Content on Its Website, Lays Off Hundreds of Staffers

Vice Media CEO Bruce Dixon announced the news in an internal memo to employees on Thursday.

Business News

'This Can't Be True': Google Responds to Viral Hoax Claiming the Company Is Shutting Down Gmail

The fake news release started making its way around X on Thursday.